Interferon alfa plus ribavirin in chronic hepatitis C relapsers and non-responders to previous interferon alfa course

被引:3
作者
Salmerón, J
Vivaldi, RM
De la Mata, M
Romero, M
Moreno, JP
Aguilar, J
Palacios, A
Nogueras, F
Vignote, M
Alcántara, R
Suarez, E
Andrade, R
Rodriguez, L
Sanchez, H
Quintero, D
机构
关键词
D O I
10.1016/S0168-8278(00)81037-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:185 / 185
页数:1
相关论文
共 50 条
[11]   Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis [J].
Camma, Calogero ;
Cabibbo, Giuseppe ;
Bronte, Fabrizio ;
Enea, Marco ;
Licata, Anna ;
Attanasio, Massimo ;
Andriulli, Angelo ;
Craxi, Antonio .
JOURNAL OF HEPATOLOGY, 2009, 51 (04) :675-681
[12]   Induction treatment of chronic hepatitis C with daily interferon plus ribavirin plus amantadine is effective in non-responders to interferon plus ribavirin [J].
Stauber, R ;
Munda-Steindl, P ;
Hackl, F ;
Schüutze, K ;
Datz, C ;
Hofer, H ;
Hegenbarth, K ;
Jessner, W ;
Ferenci, P .
JOURNAL OF HEPATOLOGY, 2001, 34 :134-135
[13]   Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa [J].
Fontaine, H ;
Chaix, ML ;
Lagneau, JL ;
Bréchot, C ;
Pol, S .
LANCET, 2000, 356 (9223) :41-41
[14]   A randomized study of ribavirin plus interferon alfa vs interferon alfa alone for treatment of patients with chronic hepatitis C [J].
Lay, CS ;
Tsai, YL .
HEPATOLOGY, 1999, 30 (04) :621A-621A
[15]   Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy [J].
Wietzke-Braun, P ;
Meier, V ;
Braun, F ;
Ramadori, G .
WORLD JOURNAL OF GASTROENTEROLOGY, 2001, 7 (02) :222-227
[16]   Ribavirin plus alfa-interferon and ribavirin alone in resistant chronic hepatitis C [J].
Tripi, S ;
DiGaetano, G ;
Montalto, G ;
Soresi, M ;
Ortoleva, A ;
Migneco, G .
HEPATOLOGY, 1996, 24 (04) :1857-1857
[17]   Prolonged interferon treatment after combination interferon and ribavirin therapy in patients with chronic hepatitis C: A clinical trial of interferon relapsers and non-responders [J].
Kao, JH ;
Lai, MY ;
Chen, PJ ;
Cheng, YM ;
Chen, DS .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2001, 100 (10) :662-667
[18]   Interferon-alpha plus ribavirin combination therapy for the treatment of chronic hepatitis C in interferon non-responders [J].
Hasan, F ;
Asker, H ;
Al Shamali, M ;
Al Kalaoui, M ;
Al Nakib, B .
HEPATO-GASTROENTEROLOGY, 2000, 47 (36) :1642-1644
[19]   A randomized, controlled comparison of 5 MU versus 3 MU TIW of interferon (IFN) alfa-2b plus ribavirin in non-responders and relapsers with chronic hepatitis C. [J].
Lee, YM ;
Mikolich, DJ ;
Sepe, TE ;
Epstein, A ;
Cooley, JS ;
Brown, AM ;
Dupont, I ;
Studley, S .
HEPATOLOGY, 1999, 30 (04) :630A-630A
[20]   Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C [J].
Kanda, T. ;
Yokosuka, O. .
JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2011, 50 (01) :41-48